Michael Karbiener

2.3k total citations
56 papers, 1.8k citations indexed

About

Michael Karbiener is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Michael Karbiener has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Physiology and 18 papers in Cancer Research. Recurrent topics in Michael Karbiener's work include MicroRNA in disease regulation (17 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Voice and Speech Disorders (9 papers). Michael Karbiener is often cited by papers focused on MicroRNA in disease regulation (17 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Voice and Speech Disorders (9 papers). Michael Karbiener collaborates with scholars based in Austria, Germany and United States. Michael Karbiener's co-authors include Marcel Scheideler, Ez‐Zoubir Amri, Peter Opriessnig, Gérard Ailhaud, Christian Dani, Christine Papak, Christoph Fischer, Thomas R. Kreil, Didier F. Pisani and Johannes Grillari and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Michael Karbiener

56 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Karbiener Austria 22 985 846 443 220 149 56 1.8k
Victoria Wang United States 22 722 0.7× 449 0.5× 327 0.7× 446 2.0× 200 1.3× 34 2.1k
Duan Ma China 26 1.7k 1.7× 978 1.2× 117 0.3× 317 1.4× 88 0.6× 96 2.6k
Alessandra Pasut United States 15 1.7k 1.7× 516 0.6× 376 0.8× 192 0.9× 534 3.6× 20 2.6k
Ming Tang China 21 965 1.0× 318 0.4× 298 0.7× 99 0.5× 85 0.6× 63 1.8k
Alba De Martino Spain 20 857 0.9× 186 0.2× 389 0.9× 213 1.0× 143 1.0× 35 1.8k
Corinne Luedemann United States 18 1.1k 1.1× 265 0.3× 130 0.3× 171 0.8× 199 1.3× 27 1.8k
Ji‐Liang Li China 17 914 0.9× 609 0.7× 108 0.2× 204 0.9× 55 0.4× 41 1.6k
Jeoffrey Schageman United States 14 1.3k 1.3× 720 0.9× 161 0.4× 73 0.3× 33 0.2× 24 1.7k
Marah C. Runtsch United States 14 1.4k 1.4× 854 1.0× 115 0.3× 151 0.7× 77 0.5× 22 2.1k
Dagmar Riemann Germany 29 840 0.9× 279 0.3× 205 0.5× 156 0.7× 57 0.4× 79 2.2k

Countries citing papers authored by Michael Karbiener

Since Specialization
Citations

This map shows the geographic impact of Michael Karbiener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Karbiener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Karbiener more than expected).

Fields of papers citing papers by Michael Karbiener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Karbiener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Karbiener. The network helps show where Michael Karbiener may publish in the future.

Co-authorship network of co-authors of Michael Karbiener

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Karbiener. A scholar is included among the top collaborators of Michael Karbiener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Karbiener. Michael Karbiener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karbiener, Michael, Gerhard Kindle, Isabelle Meyts, et al.. (2024). Clinical efficacy of SARS‐CoV‐2 Omicron ‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency. Journal of Medical Virology. 96(6). e29738–e29738. 1 indexed citations
2.
Farcet, Maria R., et al.. (2024). Parvovirus B19 rebound outbreak 2024 and implications for blood‐ and plasma‐product safety. Transfusion. 64(12). 2218–2221. 9 indexed citations
3.
Karbiener, Michael, et al.. (2023). Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC. International Journal of Molecular Sciences. 24(9). 7920–7920. 8 indexed citations
4.
Farcet, Maria R., et al.. (2022). Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe. The Journal of Infectious Diseases. 226(8). 1396–1400. 5 indexed citations
5.
Karbiener, Michael, Maria R. Farcet, Andreas Zollner, et al.. (2022). Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines. npj Vaccines. 7(1). 22–22. 15 indexed citations
6.
Farcet, Maria R., Julia Schwaiger, Michael Karbiener, & Thomas R. Kreil. (2022). Function matters: Coronavirus cross-binding antibodies do not cross-neutralize. Frontiers in Medicine. 9. 924426–924426. 2 indexed citations
7.
Farcet, Maria R., et al.. (2021). Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic. The Journal of Infectious Diseases. 226(8). 1357–1361. 24 indexed citations
8.
Schwaiger, Julia, Michael Karbiener, Claudia Aberham, Maria R. Farcet, & Thomas R. Kreil. (2020). No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic. The Journal of Infectious Diseases. 222(12). 1960–1964. 41 indexed citations
9.
Kindermann, Johanna, et al.. (2020). Synthesis of “Nereid,” a new phenol‐free detergent to replace Triton X‐100 in virus inactivation. Journal of Medical Virology. 93(6). 3880–3889. 12 indexed citations
10.
Kindermann, Johanna, et al.. (2020). Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspension. Biologicals. 64. 1–9. 20 indexed citations
11.
Higareda‐Almaraz, Juan Carlos, Michael Karbiener, Maude Giroud, et al.. (2018). Norepinephrine triggers an immediate-early regulatory network response in primary human white adipocytes. BMC Genomics. 19(1). 794–794. 12 indexed citations
12.
Karbiener, Michael, et al.. (2017). Comparative proteomics of paired vocal fold and oral mucosa fibroblasts. Journal of Proteomics. 155. 11–21. 15 indexed citations
13.
Giroud, Maude, Didier F. Pisani, Michael Karbiener, et al.. (2016). miR-125b affects mitochondrial biogenesis and impairs brite adipocyte formation and function. Molecular Metabolism. 5(8). 615–625. 52 indexed citations
14.
Giroud, Maude, Michael Karbiener, Didier F. Pisani, et al.. (2016). Let-7i-5p represses brite adipocyte function in mice and humans. Scientific Reports. 6(1). 28613–28613. 41 indexed citations
15.
Khan, Abdulhameed, Hanna Dellago, Lucia Terlecki‐Ζaniewicz, et al.. (2016). SNEVhPrp19/hPso4 Regulates Adipogenesis of Human Adipose Stromal Cells. Stem Cell Reports. 8(1). 21–29. 9 indexed citations
16.
Karbiener, Michael & Marcel Scheideler. (2015). Microarray Analysis of Small Non-Coding RNAs. Methods in molecular biology. 1296. 161–171. 5 indexed citations
17.
Karbiener, Michael, Didier F. Pisani, Jurga Laurencikiene, et al.. (2015). Mesoderm-specific transcript (MEST) is a negative regulator of human adipocyte differentiation. International Journal of Obesity. 39(12). 1733–1741. 33 indexed citations
18.
Żywicki, Marek, et al.. (2012). Expression Profiling of a Heterogeneous Population of ncRNAs Employing a Mixed DNA/LNA Microarray. Journal of Nucleic Acids. 2012. 1–10. 1 indexed citations
19.
Béranger, Guillaume E., Michael Karbiener, Valentin Barquissau, et al.. (2012). In vitro brown and “brite”/“beige” adipogenesis: Human cellular models and molecular aspects. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(5). 905–914. 41 indexed citations
20.
Karbiener, Michael, et al.. (2011). MicroRNA-30c promotes human adipocyte differentiation and co-repressesPAI-1andALK2. RNA Biology. 8(5). 850–860. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Wang Breakdown of academic impact, for papers by Duan Ma Breakdown of academic impact, for papers by Alessandra Pasut Breakdown of academic impact, for papers by Ming Tang Breakdown of academic impact, for papers by Alba De Martino Breakdown of academic impact, for papers by Corinne Luedemann Breakdown of academic impact, for papers by Ji‐Liang Li Breakdown of academic impact, for papers by Jeoffrey Schageman Breakdown of academic impact, for papers by Marah C. Runtsch Breakdown of academic impact, for papers by Dagmar Riemann
Rankless by CCL
2026